| For: | Kang YB, Cai Y. Future prospect of “Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients”. World J Gastroenterol 2022; 28(20): 2248-2250 [PMID: 35721889 DOI: 10.3748/wjg.v28.i20.2248] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i20/2248.htm |
| Number | Citing Articles |
| 1 |
Chenfang Zhang, Dan Zhang, Xin Wen, Shui Liu. Drug resistance mechanisms of immunotherapy and translational strategies for reversing resistance for hepatocellular carcinoma: from bench to bedside. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1808109
|
| 2 |
Miao Guo, Congyue Zhang. Current status and challenges of immune checkpoint inhibitors in liver cancer: from monotherapy to combination strategies. Medical Oncology 2026; 43(9) doi: 10.1007/s12032-026-03355-x
|